BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36952660)

  • 1. Cystic Fibrosis Reprograms Airway Epithelial IL-33 Release and Licenses IL-33-Dependent Inflammation.
    Cook DP; Thomas CM; Wu AY; Rusznak M; Zhang J; Zhou W; Cephus JY; Gibson-Corley KN; Polosukhin VV; Norlander AE; Newcomb DC; Stoltz DA; Peebles RS
    Am J Respir Crit Care Med; 2023 Jun; 207(11):1486-1497. PubMed ID: 36952660
    [No Abstract]   [Full Text] [Related]  

  • 2. Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation.
    Chaudhary N; Datta K; Askin FB; Staab JF; Marr KA
    Am J Respir Crit Care Med; 2012 Feb; 185(3):301-10. PubMed ID: 22135344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17 primes airway epithelial cells lacking functional Cystic Fibrosis Transmembrane conductance Regulator (CFTR) to increase NOD1 responses.
    Roussel L; Rousseau S
    Biochem Biophys Res Commun; 2010 Jan; 391(1):505-9. PubMed ID: 19931506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators.
    Wang S; Niroula S; Hoffman A; Khorrami M; Khorrami M; Yuan F; Gasser GN; Choi S; Liu B; Li J; Metersky ML; Vincent M; Crum CP; Boucher RC; Karmouty-Quintana H; Huang HJ; Sheshadri A; Dickey BF; Parekh KR; Engelhardt JF; McKeon FD; Xian W
    Am J Respir Crit Care Med; 2023 Nov; 208(9):930-943. PubMed ID: 37695863
    [No Abstract]   [Full Text] [Related]  

  • 5. Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.
    Antigny F; Norez C; Dannhoffer L; Bertrand J; Raveau D; Corbi P; Jayle C; Becq F; Vandebrouck C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):83-90. PubMed ID: 20203293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.
    John G; Yildirim AO; Rubin BK; Gruenert DC; Henke MO
    Am J Respir Cell Mol Biol; 2010 Apr; 42(4):424-31. PubMed ID: 19502387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFTR inhibition mimics the cystic fibrosis inflammatory profile.
    Perez A; Issler AC; Cotton CU; Kelley TJ; Verkman AS; Davis PB
    Am J Physiol Lung Cell Mol Physiol; 2007 Feb; 292(2):L383-95. PubMed ID: 16920886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production.
    Oglesby IK; Vencken SF; Agrawal R; Gaughan K; Molloy K; Higgins G; McNally P; McElvaney NG; Mall MA; Greene CM
    Eur Respir J; 2015 Nov; 46(5):1350-60. PubMed ID: 26160865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of AMP-activated kinase by dysfunctional cystic fibrosis transmembrane conductance regulator in cystic fibrosis airway epithelial cells mitigates excessive inflammation.
    Hallows KR; Fitch AC; Richardson CA; Reynolds PR; Clancy JP; Dagher PC; Witters LA; Kolls JK; Pilewski JM
    J Biol Chem; 2006 Feb; 281(7):4231-41. PubMed ID: 16361706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.
    Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J
    Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses.
    Mueller C; Braag SA; Keeler A; Hodges C; Drumm M; Flotte TR
    Am J Respir Cell Mol Biol; 2011 Jun; 44(6):922-9. PubMed ID: 20724552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses.
    Bodas M; Mazur S; Min T; Vij N
    Respir Res; 2018 Jan; 19(1):2. PubMed ID: 29301535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis transmembrane conductance regulator does not affect neutrophil migration across cystic fibrosis airway epithelial monolayers.
    Pizurki L; Morris MA; Chanson M; Solomon M; Pavirani A; Bouchardy I; Suter S
    Am J Pathol; 2000 Apr; 156(4):1407-16. PubMed ID: 10751364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation.
    Ortiz-Muñoz G; Yu MA; Lefrançais E; Mallavia B; Valet C; Tian JJ; Ranucci S; Wang KM; Liu Z; Kwaan N; Dawson D; Kleinhenz ME; Khasawneh FT; Haggie PM; Verkman AS; Looney MR
    J Clin Invest; 2020 Apr; 130(4):2041-2053. PubMed ID: 31961827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation in cystic fibrosis: An update.
    Roesch EA; Nichols DP; Chmiel JF
    Pediatr Pulmonol; 2018 Nov; 53(S3):S30-S50. PubMed ID: 29999593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia.
    Veit G; Bossard F; Goepp J; Verkman AS; Galietta LJ; Hanrahan JW; Lukacs GL
    Mol Biol Cell; 2012 Nov; 23(21):4188-202. PubMed ID: 22973054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
    Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
    Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8.
    Bhattacharyya S; Balakathiresan NS; Dalgard C; Gutti U; Armistead D; Jozwik C; Srivastava M; Pollard HB; Biswas R
    J Biol Chem; 2011 Apr; 286(13):11604-15. PubMed ID: 21282106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokines TNF-α and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators.
    Rehman T; Karp PH; Tan P; Goodell BJ; Pezzulo AA; Thurman AL; Thornell IM; Durfey SL; Duffey ME; Stoltz DA; McKone EF; Singh PK; Welsh MJ
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34166230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs.
    Keiser NW; Birket SE; Evans IA; Tyler SR; Crooke AK; Sun X; Zhou W; Nellis JR; Stroebele EK; Chu KK; Tearney GJ; Stevens MJ; Harris JK; Rowe SM; Engelhardt JF
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):683-94. PubMed ID: 25317669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.